These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31671453)
21. A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt. Manigart O; Trotter C; Findlow H; Assefa A; Mihret W; Moti Demisse T; Yeshitela B; Osei I; Hodgson A; Quaye SL; Sow S; Coulibaly M; Diallo K; Traore A; Collard JM; Moustapha Boukary R; Djermakoye O; Mahamane AE; Jusot JF; Sokhna C; Alavo S; Doucoure S; Ba el H; Dieng M; Diallo A; Daugla DM; Omotara B; Chandramohan D; Hassan-King M; Nascimento M; Woukeu A; Borrow R; Stuart JM; Greenwood B PLoS One; 2016; 11(2):e0147928. PubMed ID: 26872255 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso. Zoma RL; Walldorf JA; Tarbangdo F; Patel JC; Diallo AO; Nkwenkeu SF; Kambou L; Nikiema M; Ouedraogo A; Bationo AB; Ouili R; Badolo H; Sawadogo G; Krishnaswamy A; Hatcher C; Hyde TB; Aké F; Novak RT; Wannemuehler K; Mirza I; Medah I; Soeters HM J Infect Dis; 2019 Oct; 220(220 Suppl 4):S233-S243. PubMed ID: 31671442 [TBL] [Abstract][Full Text] [Related]
23. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998 [TBL] [Abstract][Full Text] [Related]
24. An evaluation of emerging vaccines for childhood meningococcal disease. Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447 [TBL] [Abstract][Full Text] [Related]
25. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization. Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915 [TBL] [Abstract][Full Text] [Related]
26. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. MenAfriCar consortium J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956 [TBL] [Abstract][Full Text] [Related]
27. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012. Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X mSphere; 2016; 1(6):. PubMed ID: 27904879 [TBL] [Abstract][Full Text] [Related]
28. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898 [TBL] [Abstract][Full Text] [Related]
29. Meningococcal carriage in the African meningitis belt. MenAfriCar Consortium Trop Med Int Health; 2013 Aug; 18(8):968-78. PubMed ID: 23682910 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa. Miller MA; Wenger J; Rosenstein N; Perkins B Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623 [TBL] [Abstract][Full Text] [Related]
31. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017. Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt. Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699 [TBL] [Abstract][Full Text] [Related]
33. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project. Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665 [TBL] [Abstract][Full Text] [Related]
34. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Trotter CL; Lingani C; Fernandez K; Cooper LV; Bita A; Tevi-Benissan C; Ronveaux O; Préziosi MP; Stuart JM Lancet Infect Dis; 2017 Aug; 17(8):867-872. PubMed ID: 28545721 [TBL] [Abstract][Full Text] [Related]
38. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa. Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685 [TBL] [Abstract][Full Text] [Related]
39. Implementation of Case-Based Surveillance and Real-time Polymerase Chain Reaction to Monitor Bacterial Meningitis Pathogens in Chad. Paye MF; Gamougame K; Payamps SK; Feagins AR; Moto DD; Moyengar R; Naïbeï N; Vuong J; Diallo AO; Tate A; Soeters HM; Wang X; Acyl MA J Infect Dis; 2019 Oct; 220(220 Suppl 4):S182-S189. PubMed ID: 31671450 [TBL] [Abstract][Full Text] [Related]
40. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine. Nelson CB; Birmingham M; Costa A; Daviaud J; Perea W; Kieny MP; Tarantola D Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S15-22. PubMed ID: 17413077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]